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OBJECTIVE: We investigated the association of customarily used renal function parameters with early (defined as the period of 90 days post-
discharge) rehospitalization due to HF and all-cause mortality, and long-term all-cause mortality in HF patients.
BACKGROUND: In heart failure (HF) patients renal dysfunction represents impaired tissue perfusion and is a predictor of poor outcome.
PARTNERSHIPS 
 
 
 
 
 
 
 
 
 
 
 
N=65 HF patients
Mean age: 79.2 (SD 10.8)
Median follow-up : 13.7 months
[Q1: 6.7 to Q3: 18.9]
RESULTS
Characteristics Patients (n=65)
Age, mean (SD) 79.2 ± 10.8
Female Gender, n (%) 37 (56.9)
Hypertension, n (%) 58 (89.2)
Type 2 Diabetes, n (%) 25 (38.5)
Dyslipidemia, n (%) 41 (63.1)
Obesity, n (%) 17 (26.2)
Atrial Fibrillation, n (%) 28 (43.1)
Family History of CVD, n (%) 31 (47.7)
Tabagism, n (%) 21 (32.3)
Chronic Kidney Disease, n (%) 34 (52.3)
GFR (Baseline), median 57.8 (43.8 - 82.2)
GFR (Admission), median 47.9 (33.2 - 68.1)
Urea (Baseline), median 47.0 (35 - 76)
Urea (Admission), median 64.0 (38 - 97)
Creatinine (Baseline), median 1.0 (0.8 - 1.4)
Creatinine (Admission), median 1.3 (1.0 - 1.8)
Cardiorenal Syndrome, n (%) 35 (53.8)
Previous Acute Myocardial Infarction, n (%) 27 (41.5)
Hypertensive Cardiomyopathy, n (%) 44 (67.7)
Ischemic Cardiomyopathy, n (%) 22 (33.8)
Valvular Cardiomyopathy, n (%) 56 (86.2)
LVEF, mean (SD) 50.38 ± 19.07
Tricuspid Annulus Plane Systolic excursion (TAPSE), mean (SD) 17.7 ± 4.0
Pulmonary Artery Systolic Pressure (PSAP), median 34.60 (25.94 - 50.05)
Systolic Blood Pressure (Admission), median 145.0 (121 - 163)
Diastolic Blood Pressure (Admission), median 145.0 (121 - 163)
NYHA class III, n (%) 43 (66.2)
ACE Inhibitor, n (%) 43 (66.2)
Beta Blocker, n (%) 38 (58.5)
Mineralocorticoid Receptor Antagonists, n (%) 19 (29.2)
Angiotensin II Receptor Blocker, n (%) 11 (16.9)
Loop Diuretic, n (%) 54 (83.1)
Digoxin, n (%) 8 (12.3)
Values are median (IQR), n (%), or mean±SD. 
IQR: interquartile range and minimum/maximum, SD: standard deviation, CVD: cardiovascular disease, GFR: glomerular filtration rate.
METHODS: Baseline and admission urea, creatinine and glomerular filtration rate (GFR) and type 1 cardiorenal syndrome (CRS) were evaluated in patients
hospitalized with acute decompensated HF in class III or IV of New York Heart Association (NYHA). Descriptive analysis was performed using t test or Wilcoxon
Rank test as applicable. Categorical variables were compared using chi-squared test or Fisher’s Exact test. Univariate Cox proportional hazard model was used
to assess the relationship between variables and outcomes.
CONCLUSION: Renal dysfunction was a reliable predictor of worse prognosis as several parameters correlated with the proposed end-points.
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Table 1 – General baseline characteristics
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Figure 1- Early Rehospitalization - Kaplan Meier: admission GFR <30 ml/min  
• Increased risk for short-term mortality was associated with:
• Baseline urea (HR: 1.145, 95% CI: 1.032-1.270, P-value=0.010),
• Admission urea (HR: 1.076, 95% CI: 1.021-1.135, P-value=0.006),
• Baseline creatinine (HR: 1.157, 95% CI: 1.009-1.328, P value=0.037),
• Admission creatinine (HR: 1.127, 95% CI: 1.055-1.204, P-value<0.001),
• Admission GFR <30 ml/min (HR: 9.791, 95% CI: 2.855-33.580, P-value<0.001).
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• Variables associated with an increased risk for long-term mortality were:
• Admission urea (HR: 1.056, 95% CI: 1.019-1.094, P-value=0.003)
• Admission creatinine (HR: 1.104, 95% CI: 1.054-1.156, P- value<0.001),
• Admission GFR <30 ml/min (HR: 3.906, 95% CI: 1.7208.871, P- value=0.001).
Figure 3- Long term mortality- Kaplan Meier: admission GFR <30 ml/min
Figure 2- Baseline comparison of subjects by short-term mortality status: Admission creatinine
• Variables associated with an increased risk for early rehospitalization were:
• Baseline urea (HR: 1.098, 95% CI: 1.022-1.179, P-value=0.01)
• Admission urea (HR: 1.048, 95% CI: 1.013-1.084, P-value=0.006)
• Baseline creatinine (HR: 1.111, 95% CI: 1.004-1.229, P-value=0.041)
• Admission creatinine (HR: 1.047, 95% CI: 1.005-1.092, P-value=0.027)
• Admission GFR <30 mL/min (HR: 3.535, 95% CI: 1.467-8.518, P-value=0.005).
• According to descriptive analysis short-term mortality risk was related with prior of 
chronic kidney disease (CKD) (P-value=0.024). 
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Figure 4 - Baseline comparison of subjects by short-term mortality status: Chronic kidney disease
Figure 5 - Short-term mortality - Kaplan Meier: Cardiorenal syndrome
